In today’s recent session, 4.65 million shares of the ABVC BioPharma Inc (NASDAQ:ABVC) have been traded, and its beta is 0.75. Most recently the company’s share price was $0.44, and it changed around -$0.03 or -6.64% from the last close, which brings the market valuation of the company to $5.75M. ABVC at last check was trading at a discount to its 52-week high of $2.45, offering almost -456.82% off that amount. The share price’s 52-week low was $0.41, which indicates that the recent value has risen by an impressive 6.82% since then. We note from ABVC BioPharma Inc’s average daily trading volume that its 10-day average is 78330.0 shares, with the 3-month average coming to 150.68K.
ABVC BioPharma Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ABVC as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ABVC BioPharma Inc (NASDAQ:ABVC) trade information
Instantly ABVC has been showing red trend so far today with a performance of -6.64% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.5470 on recent trading dayincreased the stock’s daily price by 19.56%. The company’s shares are currently down -61.79% year-to-date, but still down -18.98% over the last five days. On the other hand, ABVC BioPharma Inc (NASDAQ:ABVC) is -15.76% down in the 30-day period. We can see from the shorts that 0.19 million shares have been sold at a short interest cover period of 0.7 day(s).
ABVC BioPharma Inc (NASDAQ:ABVC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 22.93% of ABVC BioPharma Inc shares, and 3.01% of them are in the hands of institutional investors. The stock currently has a share float of 3.91%.
